Whole Health Rx does not collect or store yourPHI directly
Change Your Life Today For Only $249/month Section 8: Research Citations Section 8: Research Citations Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has emerged as a promising therapy for type 2 diabetes mellitus due to its potent glucose-lowering effects and cardiovascular benefits
[1] This dual effect helps improve glycemic control without causing significant hypoglycemia in most patients, though the risk increases when combined with insulin or sulfonylureas
Michael Snyder, medical director of the Bariatric Surgery Center at Rose Medical Center and obesity specialist at FuturHealth
10.1016/j.ejogrb.2017.04.042 29 DhamangaonkarP
Brand-name GLP-1s can cost over $12,000 per year out of pocket if you do not have insurance coverage, though recent manufacturer price cuts and discount programs have made GLP-1s more accessible for budget-conscious patients